OnCusp Therapeutics Inc et al. vs. Daiichi Sankyo Company, Limited

Explore the PTAB proceeding PGR2023-00037 filed by OnCusp Therapeutics Inc et al. on 2023-06-16. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Proceeding Overview

Proceeding Number

PGR2023-00037

Filing Date

2023-06-16

Accorded Filing Date

2023-05-16

Institution Decision Date

—

Last Modified Date

2024-01-22

Proceeding Type

PGR

Termination Date

2024-01-05

Trial Status

Terminated-Settled

Parties & Counsel

Petitioner

OnCusp Therapeutics Inc et al.

Represented By

Norton, Gerardet al

Patent Owner / Respondent

Daiichi Sankyo Company, Limited

Represented By

Weiswasser, Elizabethet al

Tribunal & Venue

Tribunal

Patent Trial and Appeal Board (USPTO)

Technology Center

TC 1600 - Biotechnology & Organic Chemistry

Patent Information

1 Patent Involved

Respondent Application Number 16613203

Respondent Patent Number 11446386

External Links

Espacenet

Google Patents

Respondent Inventor Atsuko SAITO et al

Respondent Tech Center TC 1600 - Biotechnology & Organic Chemistry

Address and Attorney/Agent Information

110 Registered Practitioners

Power of Attorney & Correspondence

Firm / Entity Name FOLEY & LARDNER LLP

Customer Number 22428

Address 3000 K STREET N.W., SUITE 600, WASHINGTON, DC, 20007-5109, UNITED STATES

Attorney / Agent Information

Reg #	Name	Phone
32904	Michael Kaminski	202-672-5490
34038	Gilberto Villacorta	202-295-4199
34202	Antoinette Konski	650-856-3700
34702	Andrew Rawlins	202-672-5349
34717	Michele Simkin	202-672-5530
35264	Stephen Maebius	202-672-5569
35421	Joseph Ziebert	414-297-5768
37288	Courtenay Brinckerhoff	202-672-5300
38072	George Beck	202-672-5300
39282	David Luettgen	414-297-5769
40580	Mark Danielson	650-251-1159
40888	Pavan Agarwal	202-672-5300
44347	Gary Solomon	214-259-0941
44458	Jeanne Gills	312-755-2583
44566	Marshall Brown	312-832-4358
44787	Paul Hunter	858-847-6733
46521	Scott Anderson	414-297-5740
47358	Andrew Mitchell	414-297-5722
48367	John Lazarus	617-226-3108
48499	Eric Sophir	202-295-4149
48580	Marcus Sprow	313-234-7150
53274	Matthew Martin	312-832-4559
53302	Christopher Mckenna	617-342-4057
54482	Sunit Talapatra	202-672-5300
55401	Jeffrey Lomprey	608-258-4288
55600	Kristel Schorr	202-672-5300
56252	Justin Sobaje	213-972-4596
56439	Alexey Saprigin	202-295-4632
56758	Navid Fanaeian	608-258-4266
57705	Brett Belden	414-319-7319
58486	Michael Houston	312-832-4500
58550	Brian Tomkins	212-338-3507
59318	Eli Mazour	202-295-4090
59349	Benjamin Berkowitz	202-672-5300
61378	Chase Brill	202-295-4787
61884	Shabbi Khan	617-342-4000
62978	Chethan Srinivasa	617-342-4000
62997	R Johnson	801-401-8942
63045	Jihwang Yeo	202-756-8181
63167	Meng Pua	617-502-3267
63216	Drew Schulte	212-261-6858
63272	Nicholas Lagerwall	608-258-4466
63527	Rebecca Hays	608-257-5035
65473	Ngai Zhang	202-295-4095
67162	Tianran Yan	202-295-4781
67563	Jonathan Goodman	212-997-1000
69186	Jason Mock	706-217-7015
69440	James Mcparland	608-258-4226
70073	Alice Lee-Dutra	858-847-6700
70238	Nicholas Zepnick	414-319-7121
70543	Michael Jespersen	313-234-7144
70614	Ching-Yang Chen	619-744-2263
70837	Austin Kim	630-696-6942
71008	David Golub	414-297-5299
71128	Christopher King	414-297-5553
71510	Sandy Ma	858-847-6763
71828	Kiri Sharon	202-295-4092
71955	Lisamarie Collins	608-257-5035
72021	Alexander Neuworth	414-319-7029
72424	Matthew Horton	202-295-4016
73296	Nikhil Pradhan	414-319-7170
73551	Robert Gentile	414-297-5458
73761	Roberto Fernandez	312-832-4530
73897	Jolene Fernandes	617-502-3261
73970	Fatih Mercan	212-682-7474
74296	Jianing Yu	213-972-4833
74448	Robert Okonowski	313-234-7191
75022	Kamyar Maserrat	202-496-7376
75239	Oyvind Dahle	301-755-4625
76187	R Glass	317-607-2227
76629	David Britton	414-319-7107
76640	Arthur Siebel	414-297-5302
77231	Kyle Rule	608-258-4467
77247	Michael Kraich	617-226-3176
77291	Tyler Wied	414-297-5034
77440	Stefan Lehnardt	801-401-8900
77689	Eugene Krakow	414-477-6811
78009	Aude Peden	1-302-355-4243
78151	Jennie Zheng	617-226-3135
78435	Skyler Vanderwerken	518-530-3299
78547	Pakin Pongcheewin	617-226-3110
78567	Rebecca Estrada	561-927-5264
78771	William Paltz	1-800-746-3592
79006	Christopher Brunnquell	858-847-6700
79186	Victoria Worcester	920-370-2112
79461	Chance Moser	214-999-4079
79486	Jasmine Wallas	917-328-9842
79709	Alexandra Bouza	248-410-6384
79751	Gage Moore	202-295-4067
79753	Andrew Salomone	414-297-5127
80228	Erin Swinstead	202-295-4041
80561	Timothy Gamache	617-342-4033
80840	Fadi Istelinides	214-999-3091
81046	Jacob Mccomis	414-271-2400
81291	Jun Young Kim	608-258-4252
81364	Lauren Long	630-240-2216
81486	William Olson	414-297-5169
81737	Rachel Peters	214-999-3106
81916	Brandon Schwechter	808-847-6700
81966	Charles Moreno	414-297-5099
81972	Theodore Reimann	312-832-4577
81987	Taryn Trusty	312-832-5120
82082	Luke Hyndiuk	414-297-5078
82395	Molly Teske	414-297-5086
82750	Mahmoud Ramadan	617-.34-2.4073
82789	Sarah Tang	617-226-3126
82882	Rebecca Kimmelfield	313-234-2749
83170	James Radwill	262-497-7060
83172	Victoria Smith	202-295-4147
83328	Priya Dave	630-842-2815

Proceeding Documents

119

Notice: refund approved NOTICE

2024-01-22 FILING PARTY: BOARD

Download

Petitioner's Request for Refund of Post-Institution Fees OTHER

2024-01-12 FILING PARTY: PETITIONER

Download

Termination Decision: Pre-DI settlement TERMINATE

2024-01-05 FILING PARTY: BOARD

Download

Joint Motion to Terminate Post-Grant Review MOTION

2023-12-20 FILING PARTY: PETITIONER

Download

Joint Request to File Settlement Documents Under Seal MOTION

2023-12-20 FILING PARTY: PETITIONER

Download

OnCusp Therapeutics Inc et al. vs. Daiichi Sankyo Company, Limited

Proceeding Overview

Parties & Counsel

Petitioner

OnCusp Therapeutics Inc et al. Follow

Represented By

Patent Owner / Respondent

Daiichi Sankyo Company, Limited Follow

Represented By

Tribunal & Venue

Patent Information

Address and Attorney/Agent Information

Power of Attorney & Correspondence

Attorney / Agent Information

Proceeding Documents

Notice: refund approved NOTICE

Petitioner's Request for Refund of Post-Institution Fees OTHER

Termination Decision: Pre-DI settlement TERMINATE

Joint Motion to Terminate Post-Grant Review MOTION

Joint Request to File Settlement Documents Under Seal MOTION

Petitioner's Updated Mandatory Notice NOTICE

Ex. 2003 - Charlton-Expression and Isolation Exhibit

Ex. 2001 - Parham 2005_Part5 Exhibit

Ex. 2001 - Parham 2005_Part2 Exhibit

Ex. 2001 - Parham 2005_Part3 Exhibit

Ex. 2001 - Parham 2005_Part4 Exhibit

Ex. 2002 - USPTO Anitbodies Slides Exhibit

Patent Owner's Preliminary Response POPR

Ex. 2001 - Parham 2005_Part1 Exhibit

Power of Attorney NOTICE

Petitioner's Updated Mandatory Notice NOTICE

Notice: Notice filing date accorded NOTICE

Notice : Power of Attorney NOTICE

Notice : Mandatory Notice NOTICE

Ex. 1002 Certified 386 Prosecution History_Part 09 Exhibit

Ex. 1010_Janeway Exhibit

Ex. 1002 Certified 386 Prosecution History_Part 22 Exhibit

Ex. 1013_Bhattacharyya Exhibit

Ex. 1002 Certified 386 Prosecution History_Part 10 Exhibit

Ex. 1036_Golay Exhibit

Ex. 1038 162 App Prosecution History_Part_06 Exhibit

Ex. 1038 162 App Prosecution History_Part_18 Exhibit

Ex. 1038 162 App Prosecution History_Part_19 Exhibit

Ex. 1038 162 App Prosecution History_Part_10 Exhibit

Ex. 1002 Certified 386 Prosecution History_Part 32 Exhibit

Ex. 1038 162 App Prosecution History_Part_21 Exhibit

Ex. 1020_Riedl Exhibit

Ex. 1002 Certified 386 Prosecution History_Part 08 Exhibit

Ex. 1002 Certified 386 Prosecution History_Part 37 Exhibit

Ex. 1038 162 App Prosecution History_Part_08 Exhibit

Ex. 1030_Kochert Exhibit

Ex. 1038 162 App Prosecution History_Part_20 Exhibit

Ex. 1031_Mandell Exhibit

Ex. 1015_Peters Exhibit

Ex. 1002 Certified 386 Prosecution History_Part 14 Exhibit

Ex. 1002 Certified 386 Prosecution History_Part 15 Exhibit

Ex. 1008_Chiu Exhibit

Notice : Power of Attorney NOTICE

Ex. 1002 Certified 386 Prosecution History_Part 05 Exhibit

Ex. 1001_US11446386 Exhibit

Ex. 1002 Certified 386 Prosecution History_Part 36 Exhibit

Ex. 1019_Saw Exhibit

Ex. 1038 162 App Prosecution History_Part_16 Exhibit

Ex. 1002 Certified 386 Prosecution History_Part 20 Exhibit

Ex. 1026_Shimazui Exhibit

Ex. 1002 Certified 386 Prosecution History_Part 06 Exhibit

Ex. 1002 Certified 386 Prosecution History_Part 12 Exhibit

Ex. 1002 Certified 386 Prosecution History_Part 18 Exhibit

Ex. 1002 Certified 386 Prosecution History_Part 34 Exhibit

Ex. 1002 Certified 386 Prosecution History_Part 03 Exhibit

Ex. 1002 Certified 386 Prosecution History_Part 27 Exhibit

Ex. 1002 Certified 386 Prosecution History_Part 30 Exhibit

Ex. 1002 Certified 386 Prosecution History_Part 26 Exhibit

Ex. 1005_W02016024195A1 to Bialucha_Novartis Exhibit

Ex. 1038 162 App Prosecution History_Part_05 Exhibit

Ex. 1014_Chalouni Exhibit

Ex. 1022_Sievers Exhibit

Ex. 1002 Certified 386 Prosecution History_Part 21 Exhibit

Ex. 1033_Muchekehu Exhibit

Ex. 1027_Sancisi Exhibit

OnCusp Therapeutics Inc et al.

Daiichi Sankyo Company, Limited